The trajectory of companies tied to iconic drugs like Viagra presents a complex investment picture. While the initial rise of copyright, fueled by Viagra's unprecedented popularity, generated substantial wealth , the patent expiration in key territories has introduced significant risk . Investors are now assessing the effect of rival medications ,